Amyloid formation in heterogeneous environments: Islet amyloid polypeptide glycosaminoglycan interactions

Journal of Molecular Biology

Volumn 425, Issue 3, 2013, Pages 492-505

  Wang, Hui ^a   Cao, Ping ^a   Raleigh, Daniel P ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

amylin; amyloid; extracellular matrix; glycosaminoglycan; IAPP

Indexed keywords

AMYLIN; AMYLOID; CHONDROITIN SULFATE; DERMATAN SULFATE; EPIGALLOCATECHIN GALLATE; GLUCURONIC ACID; GLYCOSAMINOGLYCAN; N ACETYLGLUCOSAMINE; THIOFLAVINE;

ARTICLE; BINDING ASSAY; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; DISULFIDE BOND; EXTRACELLULAR MATRIX; FLUORESCENCE RESONANCE ENERGY TRANSFER; IONIC STRENGTH; LIPID MEMBRANE; LIPID VESICLE; MOLECULAR WEIGHT; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; STATIC ELECTRICITY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84872849919     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2012.11.003     Document Type: Article

References (61)

1. M. Vendruscolo, J. Zurdo, C.E. MacPhee, and C.M. Dobson Protein folding and misfolding: a paradigm of self-Assembly and regulation in complex biological systems Philos. Trans. R. Soc.; A 361 2003 1205 1222
2. J.D. Sipe Amyloidosis Crit. Rev. Clin. Lab. Sci. 31 1994 325 354
3. M.D. Kirkitadze, G. Bitan, and D.B. Teplow Paradigm shifts in Alzheimer's disease and other neuro degenerative disorders: the emerging role of oligomeric assemblies J. Neurosci. Res. 69 2002 567 577
4. A. Lorenzo, B. Razzaboni, G.C. Weir, and B.A. Yankner Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus Nature 368 1994 756 760
5. J.R. Silveira, G.J. Raymond, A.G. Hughson, R.E. Race, V.L. Sim, S.F. Hayes, and B. Caughey The most infectious prion protein particles Nature 437 2005 257 261
6. L.L. Blazer, and R.R. Neubig Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles Neuropsychopharmacology 34 2009 126 141
7. T. Takahashi, and H. Mihara Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation Acc. Chem. Res. 41 2008 1309 1318
8. F.L. Meng, D.P. Raleigh, and A. Abedini Combination of kinetically selected inhibitors in trans leads to highly effective inhibition of amyloid formation J. Am. Chem. Soc. 132 2010 14340 14342
9. F. Meng, A. Abedini, A. Plesner, C.B. Verchere, and D.P. Raleigh The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity Biochemistry 49 2010 8127 8133
10. F. Meng, A. Abedini, A. Plesner, C.T. Middleton, K.J. Potter, and M.T. Zanni The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation J. Mol. Biol. 400 2010 555 566
11. L.M. Yan, M. Tatarek-Nossol, A. Velkova, A. Kazantzis, and A. Kapurniotu Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis Proc. Natl Acad. Sci. USA 103 2006 2046 2051
12. A. Abedini, F.L. Meng, and D.P. Raleigh A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor J. Am. Chem. Soc. 129 2007 11300 11301
13. S.M. Chafekar, H. Malda, M. Merkx, E.W. Meijer, D. Viertl, and H.A. Lashuel Branched KLVFF tetramers strongly potentiate inhibition of beta-Amyloid aggregation ChemBioChem 8 2007 1857 1864
14. J. van Horssen, P. Wesseling, L.P. van den Heuvel, R.M. de Waal, and M.M. Verbeek Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders Lancet Neurol. 2 2003 482 492
15. A.D. Snow, and T.N. Wight Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses Neurobiol. Aging 10 1989 481 497
16. S. Inoue Basement membrane and beta amyloid fibrillogenesis in Alzheimer's disease International Review of Cytology - a Survey of Cell Biology vol. 210 2001 Academic Press Inc. San Diego 121 161
17. S. Potter-Perigo, R.L. Hull, C. Tsoi, K.R. Braun, S. Andrikopoulos, and J. Teague Proteoglycans synthesized and secreted by pancreatic islet beta-cells bind amylin Arch. Biochem. Biophys. 413 2003 182 190
18. J.B. Ancsin Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit Amyloid 10 2003 67 79
19. I.D. Young, L. Ailles, S. Narindrasorasak, R. Tan, and R. Kisilevsky Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus Arch. Pathol. Lab. Med. 116 1992 951 954
20. M.J. Bonifacio, Y. Sakaki, and M.J. Saraiva 'In vitro' amyloid fibril formation from transthyretin: the influence of ions and the amyloidogenicity of TTR variants Biochim. Biophys. Acta 1316 1996 35 42
21. V.J. McParland, N.M. Kad, A.P. Kalverda, A. Brown, P. Kirwin-Jones, and M.G. Hunter Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro Biochemistry 39 2000 8735 8746
22. R. Kayed, J. Bernhagen, N. Greenfield, K. Sweimeh, H. Brunner, W. Voelter, and A. Kapurniotu Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro J. Mol. Biol. 287 1999 781 796
23. S.E. Kahn, S. Andrikopoulos, and C.B. Verchere Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes Diabetes 48 1999 241 253
24. G.J. Cooper, A.C. Willis, A. Clark, R.C. Turner, R.B. Sim, and K.B. Reid Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients Proc. Natl Acad. Sci. USA 84 1987 8628 8632
25. A. Clark, C.A. Wells, I.D. Buley, J.K. Cruickshank, R.I. Vanhegan, and D.R. Matthews Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes Diabetes Res. Clin. Pract. 9 1988 151 159
26. P. Westermark, C. Wernstedt, E. Wilander, D.W. Hayden, T.D. Obrien, and K.H. Johnson Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells Proc. Natl Acad. Sci. USA 84 1987 3881 3885
27. A. Clark, and M.R. Nilsson Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes? Diabetologia 47 2004 157 169
28. A. Andersson, S. Bohman, L.A.H. Borg, J.F. Paulsson, S.W. Schultz, G.T. Westermark, and P. Westermark Amyloid deposition in transplanted human pancreatic islets: a conceivable cause of their long-term failure Exp. Diabetes Res. 2008 2008 10.1155/2008/562985
29. K.J. Potter, A. Abedini, P. Marek, A.M. Klimek, S. Butterworth, and M. Driscoll Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts Proc. Natl Acad. Sci. USA 107 2010 4305 4310
30. J.D. Knight, and A.D. Miranker Phospholipid catalysis of diabetic amyloid assembly J. Mol. Biol. 341 2004 1175 1187
31. J.D. Knight, J.A. Hebda, and A.D. Miranker Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide Biochemistry 45 2006 9496 9508
32. S.A. Jayasinghe, and R. Langen Lipid membranes modulate the structure of islet amyloid polypeptide Biochemistry 44 2005 12113 12119
33. F. Meng, A. Abedini, B. Song, and D.P. Raleigh Amyloid formation by pro-islet amyloid polypeptide processing intermediates: examination of the role of protein heparan sulfate interactions and implications for islet amyloid formation in type 2 diabetes Biochemistry 46 2007 12091 12099
34. A. Abedini, S.M. Tracz, J.H. Cho, and D.P. Raleigh Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation Biochemistry 45 2006 9228 9237
35. P. Westermark, U. Engstrom, K.H. Johnson, G.T. Westermark, and C. Betsholtz Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation Proc. Natl Acad. Sci. USA 87 1990 5036 5040
36. S.H. Shim, R. Gupta, Y.L. Ling, D.B. Strasfeld, D.P. Raleigh, and M.T. Zanni Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution Proc. Natl Acad. Sci. USA 106 2009 6614 6619
37. G.M. Castillo, J.A. Cummings, W.H. Yang, M.E. Judge, M.J. Sheardown, and K. Rimvall Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation Diabetes 47 1998 612 620
38. K. Park, and C.B. Verchere Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide - implications for islet amyloid formation J. Biol. Chem. 276 2001 16611 16616
39. S. Jha, S.M. Patil, J. Gibson, C.E. Nelson, N.N. Alder, and A.T. Alexandrescu Mechanism of amylin fibrillization enhancement by heparin J. Biol. Chem. 286 2011 22894 22904
40. J.P. Solomon, S. Bourgault, E.T. Powers, and J.W. Kelly Heparin binds 8 kDa gelsolin cross-beta-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension Biochemistry 50 2011 2486 2498
41. A. Abedini, and D.P. Raleigh The role of His-18 in amyloid formation by human islet amyloid polypeptide Biochemistry 44 2005 16284 16291
42. S.B. Padrick, and A.D. Miranker Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis Biochemistry 41 2002 4694 4703
43. P.J. Marek, V. Patsalo, D.F. Green, and D.P. Raleigh Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects Biochemistry 51 2012 8478 8490
44. D.H.J. Lopes, A. Meister, A. Gohlke, A. Hauser, A. Blume, and R. Winter Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy Biophys. J. 93 2007 3132 3141
45. J.R. Brender, E.L. Lee, M.A. Cavitt, A. Gafni, D.G. Steel, and A. Ramamoorthy Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide J. Am. Chem. Soc. 130 2008 6424 6429
46. Y.A. Domanov, and P.K.J. Kinnunen Islet amyloid polypeptide forms rigid lipid-protein amyloid fibrils on supported phospholipid bilayers J. Mol. Biol. 376 2008 42 54
47. F. Evers, C. Jeworrek, S. Tiemeyer, K. Weise, D. Sellin, and M. Paulus Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study J. Am. Chem. Soc. 131 2009 9516 9521
48. J. Bieschke, J. Russ, R.P. Friedrich, D.E. Ehrnhoefer, H. Wobst, K. Neugebauer, and E.E. Wanker EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity Proc. Natl Acad. Sci. USA 107 2010 7710 7715
49. D.E. Ehrnhoefer, J. Bieschke, A. Boeddrich, M. Herbst, L. Masino, and R. Lurz EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat. Struct. Mol. Biol. 15 2008 558 566
50. D.E. Ehrnhoefer, M. Duennwald, P. Markovic, J.L. Wacker, S. Engemann, and M. Roark Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models Hum. Mol. Genet. 15 2006 2743 2751
51. P. Cao, and D.P. Raleigh Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols Biochemistry 51 2012 2670 2683
52. Z. Zhang, S.A. McCallum, J. Xie, L. Nieto, F. Corzana, and J. Jimenez-Barbero Solution structures of chemoenzymatically synthesized heparin and its precursors J. Am. Chem. Soc. 130 2008 12998 13007
53. S. Luca, W.M. Yau, R. Leapman, and R. Tycko Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR Biochemistry 46 2007 13505 13522
54. J.J. Valle-Delgado, M. Alfonso-Prieto, N.S. de Groot, S. Ventura, J. Samitier, C. Rovira, and X. Fernandez-Busquets Modulation of A beta(42) fibrillogenesis by glycosaminoglycan structure FASEB J. 24 2010 4250 4261
55. R.L. Hull, S. Zraika, J. Udayasankar, R. Kisilevsky, W.A. Szarek, T.N. Wight, and S.E. Kahn Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro Am. J. Physiol. Cell Physiol. 293 2007 C1586 C1593
56. R. Kisilevsky, W.A. Szarek, J.B. Ancsin, E. Elimova, S. Marone, S. Bhat, and A. Berkin Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-Acetamido-2-deoxy-Alpha- and beta-d-glucose - implications for the treatment of various amyloidoses Am. J. Pathol. 164 2004 2127 2137
57. S.K. Maji, M.H. Perrin, M.R. Sawaya, S. Jessberger, K. Vadodaria, and R.A. Rissman Functional amyloids as natural storage of peptide hormones in pituitary secretory granules Science 325 2009 328 332
58. P. Marek, A.M. Woys, K. Sutton, M.T. Zanni, and D.P. Raleigh Efficient microwave-Assisted synthesis of human islet amyloid polypeptide designed to facilitate the specific incorporation of labeled amino acids Org. Lett. 12 2010 4848 4851
59. A. Abedini, and D.P. Raleigh Incorporation of pseudoproline derivatives allows the facile synthesis of human IAPP, a highly amyloidogenic and aggregation-prone polypeptide Org. Lett. 7 2005 693 696
60. A. Abedini, G. Singh, and D.P. Raleigh Recovery and purification of highly aggregation-prone disulfide-containing peptides: application to islet amyloid polypeptide Anal. Biochem. 351 2006 181 186
61. J.C. Stewart Colorimetric determination of phospholipids with ammonium ferrothiocyanate Anal. Biochem. 104 1980 10 14